Small molecules are leading to big discoveries in human health. Using metabolomics, proteomics, and biophysical techniques, researchers screen for small molecules, metabolites, or proteins that target disease mechanisms. In this webinar, experts will discuss new approaches to identify small therapeutic candidates targeting diabetes and Alzheimer’s disease.
Topics to be covered
Speaker Information:
Bridget Wagner, PhD
Director, Pancreatic Cell Biology and Metabolic Disease
Institute Scientist
Broad Institute, MIT and Harvard
Gabriella Heller, PhD
Postdoctoral Fellow
University College London
Drug Discovery News
1000 N West Street | Wilmington | Delaware | 19801 | US
Email: privacy@drugdiscoverynews.com
© 2021 Old River Publications LLC. All rights reserved
Drug Discovery News needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy